You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cancer vaccine

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer Trial run by the National Cancer Institute (NCI) (Retifanlimab, Therapeutic CEA, Brachyury and MUC1

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 4, 2023

Health Behavior, Colorectal Cancer, Influenza Trial in New Orleans (Financial incentive for colorectal cancer screening,

Recruiting
  • Health Behavior
  • +6 more
  • Financial incentive for colorectal cancer screening
  • +2 more
  • New Orleans, Louisiana
    Tulane University School of Medicine
Nov 13, 2023

COPD, Lung Non-Small Cell Carcinoma, Pneumonia Trial in Buffalo (Quality-of-Life Assessment, Questionnaire Administration,

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • +7 more
  • Quality-of-Life Assessment
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 20, 2022

Colorectal Cancer Trial in Køge (Influenza Vaccines)

Completed
  • Colorectal Cancer
  • Influenza Vaccines
  • Køge, Zealand, Denmark
    Zealand University Hospital
Dec 12, 2022

Pancreatic Cancer, Pancreatic Carcinoma Trial in Hangzhou (iNeo-Vac-P01, GM-CSF)

Completed
  • Pancreatic Cancer
  • Pancreatic Carcinoma
  • iNeo-Vac-P01
  • GM-CSF
  • Hangzhou, Zhejiang, China
    Zhejiang Provincial People's Hospital
Nov 15, 2021

Cervical Cancer, Anal Cancer, Penile Cancer Trial in College Park (Personalized Chatbot Intervention, Non-Personalized Chatbot

Recruiting
  • Cervical Cancer
  • +2 more
  • Personalized Chatbot Intervention
  • +2 more
  • College Park, Maryland
    University of Maryland, College Park (Online Survey-Experiment)
Jul 17, 2023

Colo-rectal Cancer Trial (biological, drug, procedure)

Not yet recruiting
  • Colo-rectal Cancer
  • Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
  • +8 more
  • (no location specified)
Aug 28, 2023

Lynch Syndrome Trial in Puerto Rico, United States (Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP, MVA

Recruiting
  • Lynch Syndrome
  • Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP
  • +2 more
  • Duarte, California
  • +3 more
Nov 22, 2022

Cutaneous Melanoma, Stage III, Cutaneous Melanoma, Stage IV Trial in Tampa (IFx-Hu2.0)

Completed
Has Results
  • Cutaneous Melanoma, Stage III
  • Cutaneous Melanoma, Stage IV
  • IFx-Hu2.0
  • Tampa, Florida
    H. Lee Moffitt Cancer Center
Aug 5, 2022

Vaccine Response Trial in Atlanta, Decatur (Live Attenuated Yellow Fever 17D Vaccine, Quadrivalent seasonal influenza vaccine)

Not yet recruiting
  • Vaccine Response
  • Live Attenuated Yellow Fever 17D Vaccine
  • Quadrivalent seasonal influenza vaccine
  • Atlanta, Georgia
  • +2 more
Mar 25, 2023

HER2-positive Breast Cancer Trial in Tampa (Dendritic Cell (DC1) Vaccine, Trastuzumab, Pepinemab)

Recruiting
  • HER2-positive Breast Cancer
  • Dendritic Cell (DC1) Vaccine
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Dec 28, 2022

Advanced Cancer Trial in Seoul (AST-021p)

Recruiting
  • Advanced Cancer
  • Seoul, Korea, Republic of
  • +2 more
Jul 20, 2022

Castration-resistant Prostate Cancer, Metastatic Cancer, Prostate Cancer Trial in Saint Louis, Madison (pTVG-HP, pTVG-AR,

Recruiting
  • Castration-resistant Prostate Cancer
  • +2 more
  • pTVG-HP
  • +2 more
  • Saint Louis, Missouri
  • +1 more
Nov 21, 2022

Advanced Adenocarcinoma, Advanced Malignant Solid Tumor, Metastatic Adenocarcinoma Trial in Sacramento (Antineoplastic Vaccine,

Recruiting
  • Advanced Adenocarcinoma
  • +5 more
  • Antineoplastic Vaccine
  • Sargramostim
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 29, 2021

High Grade Anal Canal Intraepithelial Neoplasia, High Grade Vulvar Squamous Intraepithelial Lesion Trial in Birmingham, Seattle

Terminated
  • High Grade Anal Canal Intraepithelial Neoplasia
  • High Grade Vulvar Squamous Intraepithelial Lesion
  • Laboratory Biomarker Analysis
  • +3 more
  • Birmingham, Alabama
  • +1 more
Jan 24, 2023

Childhood Cancer, Multiple Diseases Trial in New York (Immunization Schedule patients <7 years., Immunization Schedule patients

Active, not recruiting
  • Childhood Cancer
  • Multiple Diseases
  • Immunization Schedule patients <7 years.
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center 1275 York Avenue
Aug 9, 2022

Advanced Malignant Solid Tumor Trial in Hangzhou (iNeo-Vac-P01, GM-CSF)

Active, not recruiting
  • Advanced Malignant Solid Tumor
  • iNeo-Vac-P01
  • GM-CSF
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital
Nov 15, 2021

Pancreatic Cancer Trial in Baltimore (drug, biological, radiation)

Active, not recruiting
  • Pancreatic Cancer
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 3, 2022

HPV Vaccine on Menstrual Cycle in Women of Reproductive Age

Not yet recruiting
  • Menstrual Disorder
  • Premature Ovarian Failure
  • prophylactic HPV vaccine(bivalent HPV、quadrivalent HPV、9-valent HPV)
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Cente
Apr 20, 2023

Vaccine Response Impaired Trial in Adelaide (BCG vaccine, Yellow Fever vaccine, Vancomycin Oral Capsule)

Recruiting
  • Vaccine Response Impaired
  • BCG vaccine
  • +3 more
  • Adelaide, South Australia, Australia
    South Australian Health and Medical Research Institute
Nov 17, 2023

Prostate Cancer, Non Small Cell Lung Cancer, Ovarian Cancer Trial in London, Oxford (OVM-200)

Recruiting
  • Prostate Cancer
  • +2 more
  • OVM-200
  • London, United Kingdom
  • +2 more
Apr 26, 2022

Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues Trial

Active, not recruiting
Has Results
  • Hormone-Resistant Prostate Cancer
  • +6 more
  • Pembrolizumab
  • pTVG-HP Plasmid DNA Vaccine
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Nov 8, 2022

Prostate Cancer Trial run by the National Cancer Institute (NCI) (PROSTVAC-F/TRICOM, PROSTVAC-V/TRICOM, Enzalutamide (Xtandi))

Active, not recruiting
  • Prostate Cancer
  • PROSTVAC-F/TRICOM
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 18, 2022

Head and Neck Carcinoma, Adult Disease Trial in Villejuif (HPVDC injection level dose 1, injection level dose 1, HPVDC

Recruiting
  • Head and Neck Carcinoma
  • Adult Disease
  • HPVDC injection level dose 1
  • +3 more
  • Villejuif, France
    Gustave Roussy
Aug 17, 2023

Tumors, Esophageal Tumors, Esophagus Tumor Trial run by the National Cancer Institute (NCI) (Nivolumab, Entinostat, Montanide(R)

Not yet recruiting
  • Neoplasms
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 16, 2023